Free Trade Agreement Would Be A Boon For Indian Drugmakers But A Threat To Local Companies

BMI View: A free trade agreement (FTA) between India and the Gulf Cooperation Council (GCC) will help Indian drugmakers to take a greater market share of the generic drug segment, primarily at the expense of Middle Eastern drugmakers. BMI believes the growth in generic drugs sales in the GCC will outpace the growth in patented medicine sales, especially with the upcoming patent cliff. However, generic drugs sales as a percentage of total sales will remain low as the stigma surrounding these medicines remains. The low rate of generic drug uptake will help to shelter local drugmakers from Indian competition, which

To read the full article, please choose one of the following options: